Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Healthcare Pricing Incentives topic

No spam. Unsubscribe anytime.

Senate committee hears competing views on SB 4 health-care price-incentive plan

3297133 · May 13, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Sen. Shelley Hughes, sponsor from District M (Palmer), introduced Senate Bill 4 on May 13, telling the Senate Health and Social Services Committee the bill would create an optional incentive program allowing insured patients to shop for the “best value” in health care — a mix of quality and cost — using online or phone tools provided by their insurer.

Sen. Shelley Hughes, sponsor from District M (Palmer), introduced Senate Bill 4 on May 13, telling the Senate Health and Social Services Committee the bill would create an optional incentive program allowing insured patients to shop for the “best value” in health care — a mix of quality and cost — using online or phone tools provided by their insurer.

The bill matters because committee members heard competing views on whether a price-driven incentive would lower costs without harming Alaska’s in-state health-care system. Hughes said the measure is voluntary and intended to “nudge down cost a little bit over time” by encouraging use of existing price-transparency tools; opponents argued the bill focuses too narrowly on price and risks unintended consequences.

At a public-testimony hearing, Jared Kosen, president and CEO of the Alaska Hospital and Healthcare Association, opposed SB 4. “While we agree with the importance of transparency and incentivizing cost effective care, our primary concern with Senate Bill 4 is that it solely focuses on cost without considering quality,” Kosen said. He testified that emphasizing cost alone could “incentivize care out of state,” which he said would “undermine our core services and infrastructure in Alaska.” Kosen also said differences in deductible, copay and in-network status mean a published charge or median contracted rate does not reliably show what a patient will actually pay.

Director Laurie Winghire of the Division of Insurance told the committee insurers can provide estimates of median costs now but would need statutory change to share provider-level differences openly. “My understanding from talking to the insurance companies is that we would need to change some law for them to share openly the difference between providers,” Winghire said. She added insurers could generate and provide cost-sharing estimates to enrollees but could not share individual contract rates without a change in law.

Committee members pressed on operational details. Senators asked whether the program would permit Alaskans to seek lower-cost care in the Lower 48 and how geographic comparisons would be set. Hughes pointed to bill language that ties payment information to the same policy year and a geographic region but acknowledged the bill does not define how the state’s regions would be drawn. Winghire said she would likely use insurer reporting regions already in use; she also described scenarios in which care received outside Alaska would be compared based on the region where the care was obtained.

Committee members discussed who would compute savings and pay incentives. Hughes and Winghire said insurers would calculate and pay incentives and would report annually on the number of incentives paid and participant counts. Winghire said calculations are complex because cost-sharing depends on plan details (in-network/out-of-network status, deductibles, whether an enrollee has met maximum out-of-pocket), so the insurer would need to account for those variables.

Hughes said the bill does not prevent insurers from recommending providers based on quality; she referenced a letter (included in a May 9 communication from DCCED to the committee) that contains an insurer response describing existing consumer tools and how they present value.

Formal committee action on SB 4 at the May 13 hearing was limited to procedure: Chair Dunbar opened and closed public testimony, set an amendment deadline of 5 p.m. Friday, May 16, and set the bill aside for further consideration. No vote to advance SB 4 out of committee was taken at this hearing.

Looking ahead, senators flagged follow-up needs if the bill advances: specify how geographic regions will be defined in regulation or statute, clarify what provider-level information insurers may disclose, and produce implementation cost estimates so the committee can evaluate potential administrative expenses passed to insurers and consumers.

Clarifying details raised during the hearing included the amendment deadline (5 p.m. May 16), that insurers would be responsible for calculating and paying incentives and filing an annual report on incentives paid, and that a May 9 DCCED submission to the committee includes an insurer response (identified in committee discussion as containing examples of consumer tools).